Sclérose en plaques: au-delà des traitements de première ligne [Multiple sclerosis: beyong first line therapies].
Details
Serval ID
serval:BIB_74AFB87DCACD
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Sclérose en plaques: au-delà des traitements de première ligne [Multiple sclerosis: beyong first line therapies].
Journal
Revue Médicale Suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2012
Volume
8
Number
339
Pages
946-949
Language
french
Notes
Publication types: English Abstract ; Journal Article ; ReviewPublication Status: ppublish
Abstract
We are currently experiencing a key period in the management of patients with relapsing remitting multiple sclerosis. The application of new criteria allows early diagnosis, thus at a stage when the available immune treatments are the most likely to show a good efficacy. The therapeutic offer is expanding but its complexity too. It is thus important, for a given patient, to assess as precisely as possible the degree of severity of his/her disease, in order to give the drug with the optimal risk/benefit ratio.
Keywords
Adjuvants, Immunologic/therapeutic use, Antibodies, Monoclonal, Humanized/therapeutic use, Choice Behavior, Combined Modality Therapy, Humans, Immunosuppressive Agents/therapeutic use, Immunotherapy, Multiple Sclerosis/drug therapy, Multiple Sclerosis/therapy, Patient Education as Topic, Propylene Glycols/therapeutic use, Sphingosine/analogs & derivatives, Sphingosine/therapeutic use, Therapies, Investigational/methods, Therapies, Investigational/utilization
Pubmed
Create date
23/07/2012 17:39
Last modification date
20/08/2019 15:32